Amici Pharmaceuticals
Amici Pharmaceuticals was founded in 2014 as a U.S.-based generic health care company with a focus on delivering affordable prescription products to the patient population. Amici offers a niche portfolio including ophthalmic, oral solid and liquid products and continues to work with domestic and global partners to augment its increasing line of items and drive expansion.
Cutting-edge technology and customer service are the cornerstones of Amici that consistently sets the bar among its competitors, as evidenced most recently through early proactive DSCSA readiness and compliance coupled with award-winning supply chain excellence.
For more NACDS TSE 2024 show coverage, visit: